Home › Thromboembolism › NCT05301348
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria * Men and women, 18 years old and older. * Evidence of current venous or arterial thromboembolic disease diagnosed by standard of care clinical, radiographic, or laboratory testing or acute ischemic stroke. * Informed consent provided by the subject. Exclusion Criteria * Pulmonary embolus with a need for mechanical ventilation or other ventilator support (may be on oxygen delivered by nasal cannula or mask at an FiO2 of ≤ 0.40) * Acute coronary syndrome (including unstable angina) * Significant cardiac arrhythmia (may have atrial fibrillation controlled with medication) * Intracardiac thrombus * Any embolus or thrombus requiring vascular surgery or interventional radiology to attempt acute embolectomy or thrombectomy * Sickle cell disease with vaso-occlusive crisis * Sepsis or life-threatening infection * Traumatic injury requiring hospitalization (within 30 days prior to enrollment) * Pregnancy or breastfeeding * Severe mental illness * Other conditions deemed by the investigators to put the subject at greater risk
About the study
Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
What is being tested
- Photoacoustic Flow Cytometry (device)
Sponsor: University of Arkansas · Participants: 30 · Started: Jul 26, 2023
Contact the study team
- Sanjeeva Onteddu, MD · Phone: 5016865135
Official record on ClinicalTrials.gov — NCT05301348
Locations in the U.S.
| Arkansas | Univerisity of Arkansas for Medical Sciences, Little Rock |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.